Jpmorgan Chase & CO Vanda Pharmaceuticals Inc. Transaction History

Jpmorgan Chase & CO

  • $1.14 Trillion
  • Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 138,473 shares of VNDA stock, worth $671,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,473
Previous 280,783 50.68%
Holding current value
$671,594
Previous $1.15 Million 32.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$3.91 - $6.5 $556,432 - $925,015
-142,310 Reduced 50.68%
138,473 $782,000
Q1 2024

May 10, 2024
BUY
$3.47 - $4.61 $259,389 - $344,606
74,752 Added 36.28%
280,783 $1.15 Million
Q4 2023

Feb 12, 2024
SELL
$3.38 - $4.58 $71,770 - $97,251
-21,234 Reduced 9.34%
206,031 $869,000
Q3 2023

Nov 14, 2023
BUY
$4.28 - $6.57 $409,232 - $628,190
95,615 Added 72.63%
227,265 $981,000
Q2 2023

Aug 11, 2023
SELL
$5.9 - $6.95 $449,709 - $529,742
-76,222 Reduced 36.67%
131,650 $867,000
Q1 2023

May 18, 2023
BUY
$6.18 - $7.99 $262,804 - $339,774
42,525 Added 25.72%
207,872 $1.41 Million
Q1 2023

May 11, 2023
SELL
$6.18 - $7.99 $345,690 - $446,936
-55,937 Reduced 25.28%
165,347 $1.12 Million
Q4 2022

Feb 13, 2023
BUY
$6.87 - $10.96 $510,599 - $814,580
74,323 Added 50.57%
221,284 $1.64 Million
Q3 2022

Nov 14, 2022
BUY
$9.44 - $11.76 $395,054 - $492,144
41,849 Added 39.81%
146,961 $1.45 Million
Q2 2022

Aug 11, 2022
SELL
$9.31 - $11.84 $2.41 Million - $3.06 Million
-258,656 Reduced 71.1%
105,112 $1.15 Million
Q1 2022

May 11, 2022
BUY
$10.84 - $16.55 $181,201 - $276,649
16,716 Added 4.82%
363,768 $4.11 Million
Q4 2021

Feb 10, 2022
SELL
$15.69 - $21.14 $46,097 - $62,109
-2,938 Reduced 0.84%
347,052 $5.44 Million
Q3 2021

Nov 12, 2021
BUY
$15.35 - $21.27 $5.37 Million - $7.44 Million
349,990 New
349,990 $6 Million

Others Institutions Holding VNDA

# of Institutions
155
Shares Held
44.7M
Call Options Held
136K
Put Options Held
220K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $274M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email